Out-of-Pocket Spending for Insulin by Medicare Beneficiaries After Monthly Caps
Listen to this summary
This study aimed to evaluate the impact of the $35 monthly cap on out-of-pocket insulin spending for Medicare beneficiaries with type 2 diabetes, implemented in 2021 and expanded in 2023. The findings indicated that the cap significantly reduced insulin costs, increased insulin usage, and led to modest improvements in blood glucose levels, suggesting that such federal cost-sharing policies could enhance medication access and adherence for chronic disease management.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from JAMA internal medicine
View all →May 4, 2026 · JAMA internal medicine
Treatment of Anxiety for Adults in Primary Care Settings: A Review
May 4, 2026 · JAMA internal medicine
Federal Enforcement Actions Against Medicare Advantage Plans
Apr 27, 2026 · JAMA internal medicine
The Oncology Care Model and Initiation of Systemic Therapy for Cancer
Apr 27, 2026 · JAMA internal medicine
Mailed Outreach for Colorectal Cancer Screening in Community Health Centers: The CARES Pragmatic Cluster Randomized Clinical Trial
Apr 20, 2026 · JAMA internal medicine
Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Clinical Trial
Apr 20, 2026 · JAMA internal medicine
Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial
More in Internal Medicine
View all →May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · European heart journal
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
